Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Medx Health's Enterprise Value is C$26.10 Mil.
Medx Health's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 was C$-2.01 Mil. Therefore, Medx Health's EV-to-EBIT ratio for today is -13.00.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Medx Health's Enterprise Value is C$26.10 Mil.
Medx Health's EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 was C$-1.95 Mil. Therefore, Medx Health's EV-to-EBITDA ratio for today is -13.39.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Medx Health's Enterprise Value is C$26.10 Mil.
Medx Health's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 was C$0.37 Mil. Therefore, Medx Health's EV-to-Revenue ratio for today is 70.91.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Medx Health's Enterprise Value is C$26.10 Mil.
Medx Health's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was C$-2.53 Mil. Therefore, Medx Health's EV-to-FCF ratio for today is -10.32.
Medx Health Enterprise Value Historical Data
The historical data trend for Medx Health's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Medx Health's Enterprise Value
For the Medical Devices subindustry, Medx Health's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medx Health's Enterprise Value Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medx Health's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Medx Health's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Medx Health's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medx Health (TSXV:MDX) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Medx Health's current Enterprise Value is C$26.10 Mil.
Medx Health's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-2.01 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Medx Health's current Enterprise Value is C$26.10 Mil.
Medx Health's EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-1.95 Mil.
Medx Health's current Enterprise Value is C$26.10 Mil.
Medx Health's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.37 Mil.
Medx Health's current Enterprise Value is C$26.10 Mil.
Medx Health's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-2.53 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medx Health Enterprise Value Related Terms
Thank you for viewing the detailed overview of Medx Health's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Medx Health Corp is engaged in the development, manufacturing, and marketing of skin-related screening tools and phototherapy devices for pain relief and tissue repair. Its two main product lines are; SIAscopy, a medical device technology that is used to scan skin for suspicious moles and lesions; and Phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide effective treatment of pain and tissue damage in the rehabilitation market. It derives key revenue from the sale of Phototherapeutic lasers. The company sells its products internationally, of which prime revenue is generated in Canada and the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSXV:MDX has been successfully added to your 